Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 536

1.

Oncostatin M is a potential agent for the treatment of obesity and related metabolic disorders: a study in mice.

Komori T, Tanaka M, Furuta H, Akamizu T, Miyajima A, Morikawa Y.

Diabetologia. 2015 May 14. [Epub ahead of print]

PMID:
25972231
2.

Intravesical dual PI3K/mTOR complex 1/2 inhibitor NVP-BEZ235 therapy in an orthotopic bladder cancer model.

Matsushima M, Kikuchi E, Matsumoto K, Hattori S, Takeda T, Kosaka T, Miyajima A, Oya M.

Int J Oncol. 2015 May 11. doi: 10.3892/ijo.2015.2995. [Epub ahead of print]

PMID:
25963317
3.

Effect of γ-Cyclodextrin Inclusion Complex on the Absorption of R-α-Lipoic Acid in Rats.

Uchida R, Iwamoto K, Nagayama S, Miyajima A, Okamoto H, Ikuta N, Fukumi H, Terao K, Hirota T.

Int J Mol Sci. 2015 May 4;16(5):10105-20. doi: 10.3390/ijms160510105.

4.

Therapeutic effect of intravesical administration of paclitaxel solubilized with poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) in an orthotopic bladder cancer model.

Tamura K, Kikuchi E, Konno T, Ishihara K, Matsumoto K, Miyajima A, Oya M.

BMC Cancer. 2015 Apr 26;15(1):317. doi: 10.1186/s12885-015-1338-2.

5.

Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer.

Ito Y, Kikuchi E, Tanaka N, Kosaka T, Suzuki E, Mizuno R, Shinojima T, Miyajima A, Umezawa K, Oya M.

BMC Cancer. 2015 Apr 29;15(1):324. doi: 10.1186/s12885-015-1315-9.

6.

Adaptive remodeling of the biliary tree: the essence of liver progenitor cell expansion.

Kok CY, Miyajima A, Itoh T.

J Hepatobiliary Pancreat Sci. 2015 Apr 19. doi: 10.1002/jhbp.250. [Epub ahead of print]

PMID:
25900773
7.

Effect of high fat intake on the pharmacokinetic profile of ivermectin in rabbits.

Miyajima A, Yamamoto Y, Hirota T.

Drug Metab Pharmacokinet. 2015 Feb 24. pii: S1347-4367(15)00016-6. doi: 10.1016/j.dmpk.2015.02.002. [Epub ahead of print]

PMID:
25887422
8.

Cell-based therapy for preventing postoperative adhesion and promoting regeneration after hepatectomy.

Inagaki NF, Inagaki FF, Kokudo N, Miyajima A.

J Hepatobiliary Pancreat Sci. 2015 Apr 15. doi: 10.1002/jhbp.247. [Epub ahead of print]

PMID:
25877017
9.

Dysfunction of blood pressure regulation in hyperhomocyteinemia model in rats.

Miyajima A, Bamba M, Muto T, Hirota T.

J Toxicol Sci. 2015;40(2):211-21. doi: 10.2131/jts.40.211.

10.

Solifenacin or mirabegron could improve persistent overactive bladder symptoms after dutasteride treatment in patients with benign prostatic hyperplasia.

Maeda T, Kikuchi E, Hasegawa M, Ishioka K, Hagiwara M, Miyazaki Y, Shinojima T, Miyajima A, Oya M.

Urology. 2015 May;85(5):1151-5. doi: 10.1016/j.urology.2015.01.028. Epub 2015 Mar 12.

PMID:
25770728
11.

Prognostic Impact of Renin-Angiotensin System Blockade on Renal Cell Carcinoma After Surgery.

Miyajima A, Yazawa S, Kosaka T, Tanaka N, Shirotake S, Mizuno R, Kikuchi E, Oya M.

Ann Surg Oncol. 2015 Feb 18. [Epub ahead of print]

PMID:
25691280
12.

How does visceral obesity affect surgical performance in laparoscopic radical nephrectomy?

Yuge K, Miyajima A, Jinzaki M, Kaneko G, Hagiwara M, Hasegawa M, Takeda T, Kikuchi E, Nakagawa K, Oya M.

Jpn J Clin Oncol. 2015 Apr;45(4):373-7. doi: 10.1093/jjco/hyv001. Epub 2015 Jan 30.

PMID:
25637501
13.

The implications of prostate-specific antigen density to predict clinically significant prostate cancer in men ≤ 50 years.

Kosaka T, Mizuno R, Shinojima T, Miyajima A, Kikuchi E, Tanaka N, Shinoda K, Morita S, Mikami S, Oya M.

Am J Clin Exp Urol. 2014 Dec 25;2(4):332-6. eCollection 2014.

14.

Adaptive remodeling of the biliary architecture underlies liver homeostasis.

Kaneko K, Kamimoto K, Miyajima A, Itoh T.

Hepatology. 2015 Jun;61(6):2056-66. doi: 10.1002/hep.27685. Epub 2015 Apr 22.

PMID:
25572923
15.

Oncostatin M maintains the hematopoietic microenvironment in the bone marrow by modulating adipogenesis and osteogenesis.

Sato F, Miyaoka Y, Miyajima A, Tanaka M.

PLoS One. 2014 Dec 31;9(12):e116209. doi: 10.1371/journal.pone.0116209. eCollection 2014.

16.

Activation of aryl hydrocarbon receptor promotes invasion of clear cell renal cell carcinoma and is associated with poor prognosis and cigarette smoke.

Ishida M, Mikami S, Shinojima T, Kosaka T, Mizuno R, Kikuchi E, Miyajima A, Okada Y, Oya M.

Int J Cancer. 2015 Jul 15;137(2):299-310. doi: 10.1002/ijc.29398. Epub 2015 Jan 8.

PMID:
25523818
17.

Use of mouse liver mesothelial cells to prevent postoperative adhesion and promote liver regeneration after hepatectomy.

Inagaki NF, Inagaki FF, Kokudo N, Miyajima A.

J Hepatol. 2015 May;62(5):1141-7. doi: 10.1016/j.jhep.2014.12.010. Epub 2014 Dec 13.

PMID:
25514558
18.

Experimental study of pharmacokinetics of external, whole-body bathing application of ivermectin.

Miyajima A, Komoda M, Akagi K, Yuzawa K, Yoshimasu T, Yamamoto Y, Hirota T.

J Dermatol. 2015 Jan;42(1):87-9. doi: 10.1111/1346-8138.12728. Epub 2014 Dec 10.

PMID:
25492083
19.

Impact of an adjuvant chemotherapeutic regimen on the clinical outcome in high risk patients with upper tract urothelial carcinoma: a Japanese multi-institution experience.

Shirotake S, Kikuchi E, Tanaka N, Matsumoto K, Miyazaki Y, Kobayashi H, Ide H, Obata J, Hoshino K, Kaneko G, Hagiwara M, Kosaka T, Kanao K, Kodaira K, Hara S, Oyama M, Momma T, Miyajima A, Nakagawa K, Hasegawa S, Nakajima Y, Oya M.

J Urol. 2015 Apr;193(4):1122-8. doi: 10.1016/j.juro.2014.10.022. Epub 2014 Oct 13.

PMID:
25444957
20.

Visceral obesity is associated with better recurrence-free survival after curative surgery for Japanese patients with localized clear cell renal cell carcinoma.

Kaneko G, Miyajima A, Yuge K, Yazawa S, Mizuno R, Kikuchi E, Jinzaki M, Oya M.

Jpn J Clin Oncol. 2015 Feb;45(2):210-6. doi: 10.1093/jjco/hyu193. Epub 2014 Nov 23.

PMID:
25420691
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk